Clinical Trial

5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, randomized, single-center, non-inferiority interventional clinical trial comparing whole breast irradiation (WBI) to a total dose of 26 Gy in 5 fractions with simultaneous integrated boost (SIB) to the tumor bed to a total dose of 30 Gy, and WBI to a total dose of 40.05 Gy in 15 fractions with SIB to the tumor bed to a total dose of 48 Gy (standard treatment), for young or unfavorable breast cancer patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-05.
Status change: Not Yet Recruiting → Recruiting 2025-07-25
Trial Details
NCT Number NCT07020780
Lead Sponsor IRCCS San Raffaele
Conditions Breast Cancer
Enrollment 458 participants
Start Date 2025-07-25
Primary Completion 2029-06-30 (estimated)
Study Completion 2035-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-28